A study shows that women who have breast cancer within 2 years of their last pregnancy (or 2-4 years) after delivery are more likely to have a poor prognosis. Medscape Medical News
Using low-dose dexamethasone with lenalinomide instead of high-dose dexamethasone in newly diagnosed multiple myeloma patients confers a significant survival advantage and has less toxicity. Medscape Medical News